Alpha Cognition Inc. (ACOG) stock
ACOGNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/3078% above fair value
$8.60+0.68 (+8.59%)
Close on Nov 18, 2026Market cap $187.29MP/E –Yield –
Alpha Cognition pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
No pe ratio figures for Alpha Cognition
Alpha Cognition has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?